Analysis of totally implantable venous access port systems (TIVAPS) related adverse events (AEs) in metastatic colorectal cancer (mCRC) patients treated with and without bevacizumab.
Takahiro Tsushima
No relevant relationships to disclose
Keita Mori
No relevant relationships to disclose
Kentaro Yamazaki
No relevant relationships to disclose
Tomomi Hikosaka
No relevant relationships to disclose
Taro Funakoshi
No relevant relationships to disclose
Hiroyuki Tabuse
No relevant relationships to disclose
Satoshi Hamauchi
No relevant relationships to disclose
Akiko Todaka
No relevant relationships to disclose
Tomoya Yokota
No relevant relationships to disclose
Nozomu Machida
No relevant relationships to disclose
Akira Fukutomi
No relevant relationships to disclose
Yusuke Onozawa
No relevant relationships to disclose
Narikazu Boku
No relevant relationships to disclose
Hirofumi Yasui
No relevant relationships to disclose